Analysts said that Yeztugo’s forecast, which would represent 433% year-over-year growth, is achievable.

"The price has been negotiated. Scotland has access. So why are people in England still waiting?" writes Dan Glass in an op-ed for Attitude The post ‘Lenacapavir is available – how many people have ...

The South African government will undertake a further step in preparation for the implementation of the National Health Insurance (NHI) by undertaking critical investment in health infrastructure.

On 14 July 2025, the World Health Organization (WHO) issued new guidelines recommending twice-yearly injectable lenacapavir as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention.

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with drug-resistant infections in 2022. While there is still no vaccine for the ...

Government will undertake a further step in preparation of the implementation of the National Health Insurance (NHI) by ...

Gilead Sciences (NASDAQ:GILD) executives highlighted what they described as a “remarkable year” of clinical, commercial, and ...

Q4 2025 Earnings Call February 10, 2026 4:30 PM ESTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...

After a year of US funding cuts across global public health, including South Africa’s hard-hit HIV programmes, new realities ...

Add Yahoo as a preferred source to see more of our stories on Google. Two men, with one looking at the camera while the other looks past the other As Congress nears a January deadline to pass a ...